agilon health, inc. earnings per share and revenue
On Nov 04, 2025, AGL reported earnings of -0.27 USD per share (EPS) for Q3 25, missing the estimate of -0.15 USD, resulting in a -68.86% surprise. Revenue reached 1.44 billion, compared to an expected 1.44 billion, with a -0.16% difference. The market reacted with a +4.05% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 17 analysts forecast an EPS of -0.27 USD, with revenue projected to reach 1.48 billion USD, implying an increase of 0.00% EPS, and increase of 2.83% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Danaher Corporation
Report Date
Jan 28, 2026 For Q4 25
Estimate
$2.17
Actual
$2.23
Surprise
+2.56%
HCA Healthcare, Inc.
Report Date
Jan 27, 2026 For Q4 25
Estimate
$7.53
Actual
$8.14
Surprise
+8.05%
Elevance Health, Inc.
Report Date
Jan 28, 2026 For Q4 25
Estimate
$3.12
Actual
$3.33
Surprise
+6.46%
FAQ
What were agilon health, inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, agilon health, inc. reported EPS of -$0.27, missing estimates by -68.86%, and revenue of $1.44B, -0.16% below expectations.
How did the market react to agilon health, inc.'s Q3 2025 earnings?
The stock price moved up 4.05%, changed from $0.72 before the earnings release to $0.75 the day after.
When is agilon health, inc. expected to report next?
The next earning report is scheduled for Feb 25, 2026.
What are the forecasts for agilon health, inc.'s next earnings report?
Based on 17
analysts, agilon health, inc. is expected to report EPS of -$0.27 and revenue of $1.48B for Q4 2025.